Set #		Results
1	(MH “Plasmapheresis”) OR (MM “Plasma Exchange”) OR TI (plasmapheresis OR “plasma exchange”) OR AB (plasmapheresis OR “plasma exchange”)	1845
2	(MH “Anticoagulants+”) OR TI (anticoagulant OR anticoagulants OR apixaban OR rivaroxaban OR edoxaban OR dabigatran OR warfarin OR enoxaparin OR dalteparin OR heparin OR tinzaparin OR argatroban OR bivalirudin OR betrixaban OR ximelagatran) OR AB (anticoagulant OR anticoagulants OR apixaban OR rivaroxaban OR edoxaban OR dabigatran OR warfarin OR enoxaparin OR dalteparin OR heparin OR tinzaparin OR argatroban OR bivalirudin OR betrixaban OR ximelagatran)	31196
3	TI (therapy OR therapies OR therapeutic OR therapeutics) OR AB (therapy OR therapies OR therapeutic OR therapeutics)	414438
4	#1 AND #2 AND #3	46
5	#4 AND (TI (“randomized controlled trial” OR “controlled clinical trial” OR “randomized” OR “randomized” OR “randomization” OR “randomization” OR “placebo” OR “randomly” OR “trial” OR “groups” OR “systematic review” OR “meta-analysis” OR “meta-analyses” OR AB (“randomized controlled trial” OR “controlled clinical trial” OR “randomized” OR “randomized” OR “randomization” OR “randomization” OR “placebo” OR “randomly” OR “trial” OR “groups” OR “systematic review” OR “meta-analysis” OR “meta-analyses”) OR (MH “Randomized Controlled Trials” OR MH “Systematic Review” OR MH “Meta Analysis”))	4
8	#5 AND Limiters - Published Date: 20171201-	0